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Clinico-pathologic correlations in focal and segmental glomeruloscler-
osis (FGS) in rats after renal ablation. Evidence for involvement of
macrophages and lipids. H.v. Goor, V. Fidler, J.J. Weening, J. Grond,
Departments of Pathology and Medical Statistics, University of Gron-
ingen, The Netherlands. The present study was undertaken to estimate
the relative impact of a number of clinico-pathologic and glomerular
structural changes on severity and composition of FGS in rats subjected
to renal ablation. Groups of eight 11/2 nephrectomized (Nx) and sham
operated (Sh) male Wistar rats were studied at intervals of 2, 4, 8, 12,
and 16 weeks. At sacrifice, kidney tissue was embedded in glycol
methacrylate to achieve optimal morphology for light microscopy,
immunohistochemistry, and morphometry. The severity of FGS and the
extent of mesangial cellularity (MC), mesangial matrix expansion
(MME), and adhesion formation (Adh) was graded semiquantitatively
to establish injury scores. The dependence of the FGS injury score and
of the scores of MC, MME, and Adh on a variety of clinico-pathologic
and glomerular structural changes, taking account of possible correla-
tions among them, was estimated with partial correlation and multiple
linear regression analysis. The glomerular structural parameters in-
cluded hyalinosis (H, PAS stain), lipid deposits (GLD, Oil Red 0 stain),
volume expansion (GVE, morphometry), cellular proliferation (labeling
of S-phase cells by bromodeoxyuridine, BrdU), and influx of mono-
cytes (mØ), T cells, natural killer cells, B cells, and granulocytes
(immunohistochemistry with monoclonal antibodies). The clinico-
pathologic variables were urinary protein excretion (UP), fasting serum
cholesterol levels (FChol), body weight (BW), total wet kidney weight
(KW), heart weight (11W), and systolic blood pressure (SBP). The best
fitting linear regression model, explaining 91% of the total variation of
the FGS injury score (that is, multiple r2 = 0.91), included UP as the
main clinical, and H as the main structural variable. MC was explained
best by BrdU labeling (multiple r2 = 0.77). The optimal linear model
describing MME contained the variables H, mØ, and FChol (multiple r2
= 0.84). The extent of Adh was optimally described by UP, mØ, and
FChol (multiple r2 = 0.88). In conclusion, although none of these
statistically significant associations indicate causal relationships, they
identify—in addition to UP, H, and glomerular cellular proliferation—
FChol as a major independent clinical determinant, and glomerular mØ
influx as a major independent structural alteration associated with FGS
in the setting of renal ablation.
Urinary eicosanoids in relation to glomerular hyperfiltration and
progressive renal failure in rats. M.H. de Kezjzer, A.P. Provoost,
Department Pediatric Surgery, Erasmus University, Rotterdam, The
Netherlands. Chronic hyperfiltration is characterized by afferent vaso-
dilation and constriction of the efferent arterioles, and may in the long
run lead to progressive renal failure. The prostaglandin/thromboxane
system may be one of the mediators of these altered renal hemodynam-
ics. We measured the urinary excretion of vasodilating and vasocon-
stricting components of this system in Fawn-Hooded rats. Two-kidney
rats of this strain are hypertensive and proteinuric, and removal of one
kidney leads to a very rapid fall in renal function. Glornerular filtration
rate (GFR: plasma clearance of 51-Cr EDTA), effective renal plasma
flow (ERPF: plasma clearance of 1251 hippurate), urinary protein
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excretion (UV: method of Bradford) and the urinary excretion of PGE2
and TXB2 (RIA) were measured in one- and two-kidney FH rats and
compared with two-kidney WAG rats. Sham operation or uninephrec-
tomy was performed in 4-week-old male rats. The Table summarizes
the results (mean SD) 12 and 36 weeks after operation.
N
GFR ERPF
mI/mm
Week 12
WAG-2K 13 1.92 0.14 4.66 0.20
FH-2K 13 2.62 0.24 5.03 0.33
FH-lK 14 1.82 0.45 4.16 0.92
Week 36
WAG-2K 13 2.16 0.18 4.78 0.21
FH-2K 13 2.84 0.18 5.57 0.35
FH-lK 9 0.43 0.64 1.23 1.58
FF
-
UV
mg/day
PGE2 TxB2
nglday
0.41 0.02 18 5 69 39 0.8 0.3
0.52 0.02 56 28 156 71 3.0 0.8
0.43 0.03 115 47 61 29 3.2 1.0
0.45 0.03 13 5 50 19 0.8 0.4
0.51 0.04 101 56 110 20 3.3 1.1
0.31 0.08 321 162 14 7 6.4 1.7
Compared to WAG-2K rats hyperfiltration, as indicated by the elevated
GFR, FF and protein excretion, was present in FH-2K rats. This was
accompanied by a threefold higher excretion of PGE2 as well as TxB2.
In FH-lK rats the compensatory response initially lead to a GFR and
ERPF of 70%, respectively, 83% of that of FH-2K rats, and to a further
rise in protein excretion. In these rats GFR and ERPF are markedly
decreased 36 weeks after nephrectomy, while 4 rats already died due to
uremia. Severe proteinuria is present, concomitant with a decrease in
the excretion of PGE2 and a rise in the TXB2 excretion. These
experiments suggest a role for the renal eicosanoids in regulating
glomerular filtration. Hyperfiltration is associated with a relatively high
renal synthesis of the vasodilating PGE2, and the development of renal
failure is related to an increased renal synthesis of the vasoconstricting
TXB2. Interventions aimed at normalizing the unbalance in synthesis of
these eicosanoids may attenuate the development of renal failure in
these rats.
Adenine nucleotides modulate the inflammatory response in anti-Thyl
nephritis. K. Poelstra, J.F. W. Bailer, M.J. Hardonk, W. W. Bakker,
Department of Pathology, University of Groningen, The Netherlands.
Evidence is accumulating that extracellular nucleotides (ATP, ADP,
adenosine) released in the inflammatory microenvironment, may play a
role in local inflammatory reactions, including the effector limb of the
immune response. Thus, while ATP and ADP may potentiate neutrophil
responses in vitro, adenosine (ADO) inhibits activation of these cells.
However, the relevance in vivo of this group of mediators is unknown.
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Therefore, we have treated nephritic rats with ATP, ADP and ADO
analogs or saline and subsequently quantified inflammatory parameters
in glomerular sections using immuno- and histochemistry and image
analyzing techniques (analogs were used to prevent immediate degra-
dation in vivo). Rats received a single i.v. injection of monoclonal
anti-Thy! IgG (5 mg/kg) and at t = 0 and after 12 hours an i.v. injection
of either 2-chloro-ADO (group I; N 5), ADP/3S (group H; N 5),
ATPyS (group 111; N = 5) (all in a dose of 10 mg/kg) or saline (group IV;N = 6). At t = 24 hours rats were sacrificed. Results show platelet
aggregation and neutrophil influx in glomeruli of rats with anti-Thy! GN
(group IV), whereas rats of group I displayed significantly less aggre-
gation (P < 0.01). Although the number of infiltrating cells was not
changed in these rats, 02-producing activity was reduced (P < 0.01). In
contrast, rats of group II showed significantly more glomerular platelet
aggregation, but neutrophil influx and 02-production was not changed
as compared to rats of group IV. Glomeruli of rats of grdup III showed
a relatively small increase in platelet aggregation but a significant
increase in O2-producing cells (P < 0.01). These results clearly show
prothrombotic and proinflammatory effects induced by ADP and ATP
analogs in vivo in anti-Thyl nephritis, Since ATP/ADPases are able to
degrade native extracellular nucleotides (released by platelets and other
cells in the inflammatory microenvironment), and since, moreover, the
end-product of this enzyme system (ADO) is able to inhibit the
inflammatory response, these data support the pivotal antithrombotic/
inflammatory role of glomerular ATP/ADPase of the rat kidney.
Characterization of antibodies eluted from glomeruli of mice with
SLE-like syndromes. R.M. Termaat, K.J.M. Assmann, J,P.H.F. v, Son,
H.B.P.M. D.jkman, R.A.P. Koene, J.H.M. Berden, Departments of
Pathology and Nephrology, University of Nijmegen, The Netherlands.
Membranous glomerulonephritis in graft-versus-host (GVH) mice and
diffuse proliferative glomerulonephritis in MRL/lpr mice are character-
ized by the deposition of auto-antibodies in the glomeruli and are
considered as models for human SLE. We have tried to define the
specificities of the nephritogenic antibodies. Antibody was eluted from
isolated glomeruli of affected GVH or MRL/lpr kidneys and further
purified under high salt conditions to remove potentially bound anti-
gens. In ELISA the GVH eluate reacted with laminin and histones. The
MRLflpr eluate showed binding to laminin in ELISA and to DNA in
ELISA and on Crithidia, In indirect immunofluorescence (IF) on
normal mouse kidneys both eluates showed linear binding to GBM and
TBM. The MRL/lpr eluate also displayed nuclear staining. After i.v.
injection of the GVH eluate into normal mice there was linear binding
to the GBM at one hour, which changed into a granular, membranous
pattern at day 5, as determined by IF and immunoelectron microscopy.
Injection of the MRL/lpr eluate resulted also in a linear GBM-pattern at
one hour, but after five days the staining had decreased. These elution
studies of isolated glomeruli indicate that in both these models of SLE
nephritis nephritogenic antibodies to laminin, an important component
of the GBM, are present. In MRL/lpr mice this antibody specificity has
not been identified before, Antinuclear antibodies may also be involved
in the development of glomerulonephritis, but are different in the two
models since in GVH mice anti-histone antibodies and in MRL/lpr mice
anti-DNA antibodies were eluted.
In vivo renal protein handling in the rat. D. de Zeeuw, M. Haas,
Department of Medicine, Nephrology Division, State University Hos-
pital Groningen, The Netherlands. Data on the time course of in vivo
renal uptake and degradation of proteins are limited. A method was
designed to quantify both, based on y-camera monitoring of radiola-
beled proteins. For this purpose three low molecular weight proteins
(LMWP) were labeled with 1-13 1-tyramine-cellobiose (TC) and with
1-123: lysozyme (Ly), cytochrome-C (Cy) and aprotinine (Ap); different
size (molecular wt 14300, 12400, 6500 D) and similar p1(11, 10.6 and
10.5, respectively). The TC-label can be used to quantify the absolute
uptake of protein in the kidney, since the TC-label is characterized by
the fact that it is not able to leave a cell (even after protein degradation).
The renal time-activity curve of the 1-123 label reflects both uptake and
degradation, since the 1-123 label leaves the kidney, even if still coupled
to its amino acid (tyrosine). For each LMWP, the I-131-TC and 1-123
labeled protein (±20 g) was coinjected in six hydrated rats under
pentobarbital anesthesia. Unlabeled mono-iodo-tyrosine was continu-
ously infused to prevent 1-123 uncoupling from the tyrosine. Both labels
were measured over total body, heart, kidneys and bladder for eight
hours, Urine and blood samples were analyzed for labeled protein and
degradation products. TC-label of Ly, Cy, and Ap showed quantitative
similar renal uptake: 88 6, 80 8, 82 2% of injected dose, Plateau
was reached at different times: 20 1,9 1, 79 10 mm, In urine no
TC-label was recovered. 1-123 labeled protein showed lower renal
uptake due to renal breakdown, coinciding with appearance of 1-123-
Tyr in plasma and urine. Renal half-life differed considerably between
Ly, Cy, Ap: 300 48, 9 2, and 440 67 mm, respectively. In
conclusion, renal handling of proteins can be monitored in vivo.
LMWP's are nearly completely taken up by the kidneys and degraded.
However, the uptake rate and breakdown profile differ markedly
between LMWP's, and appear to be independent of the molecular
weight of individual proteins with similar p1.
Acute effect of exOgenous insulin on the pressure-natriuresis relation in
healthy men. R.O.B. Gans, H.J.G. Bib, R.J. Heine, A.J.M. Donker,
Free University Hospital, Amsterdam, The Netherlands. A role for
insulin in the pathogenesis of hypertension has been suggested. After a
two hour equilibration period (baseline), we determined, using an
euglycemic clamp, in 9 healthy men under maximal water diuresis, the
effect of three sequential infusions of insulin (50 (I), 300(11) and 500(111)
mU . kg hr' during 2 hr periods), on fractional sodium excretion
(FENa), heart rate (PR), and systolic (5) and diastolic (D) blood pressure
(BP). On separate days, control studies (C) were performed. The Table
reflects all results (mean SD) of the last half-hour of each period.
Baseline I II III
FEN% 1.0±0.2 0.8 0.la 0.8 01b 0.8 0.P
CFENa % 1.0 0.1 1.2 0.1 1.5 0.2 1.4 0.1
SBP mm Hg 133 4.5 132 4.7 139 4.8 143 4.4
C-SBP mm Hg 128 2.9 129 3.1 130 3.1 133 3.3
DBP mm Hg 70 3.4 66 2.8 67 1.7 69 2.2
C-DBPmmHg 69± 1.5 70± 2.5 71 1.9 71 2.5
PR mjn' 61 3.3 60 2.9 64 4.1 62 3.9k'
C-PR min' 58 54 2.2 54 2.8 52 3.0
a P < 0.05
b P < 0.01, baseline vs. other(s) when adjusted for differences in
control studies, paired t-tests
A decline in FENa of approximately 50% was noted with all insulin
dosages. PR increased only with the highest insulin dose. SBP also
tended to increase (P = 0.09, ANOVA). A significant correlation
between the change in FENa and the change in SBP over control values
was found (r 0.70, P = 0.003). Only after a rise in SBP of 18 mm Hg
the sodium retaining effect of insulin appeared to be offset, Insulin does,
therefore, shift the pressure-natriuresis relation in man to the right.
Increased in vitro release of IL-lB and TNFa by endotoxin-stimulated
peritoneal macrophages from CAPD patients during peritonitis.
M.W.J.A. Fieren, G.J.C.M. Van den Bemd, l.L. Bonta, Departments
of Internal Medicine 1 and Pharmacology, Erasmus University Rotter-
dam, The Netherlands. Peritoneal macrophages (PMØ) obtained from
dialysate of CAPD patients produce various mediators. Previously we
found that the basal production of various down-regulatory substances
by PMØ from CAPD patients was decreased during peritonitis com-
pared with an infection free period. In the present study we investigated
the secretion of the pro-inflammatory cytokines interleukin-lp (IL-113)
and tumor necrosis factor-a (TNFa), in PMØ either collected during an
infection free period or during peritonitis. Peritoneal cells, isolated
during 9 infection-free periods and 10 episodes of peritonitis, were
incubated (1.0 x 106/ml) for 24 hours in the absence or presence of 5
g/ml LPS. Supernatants were tested for IL-13 and TNFa contents
using an ELISA and IRMA, respectively. In the absence of LPS, the
same amounts of IL-1)3 were released during an infection free period
and an episode of peritonitis (367 76 and 439 166 pg/mi, respec-
tively, mean SEM). Similar findings were obtained for TNFa (1066
322 and 893 295 pg/mI, respectively). However, in the presence of
LPS, the release of both IL-i f3 and TNFa was more during peritonitis
(6614 2194 and 8996 5135 pg/mi, respectively) as compared to an
infection free period (1080 125 and 2615 456 pg/mi; P < 0.005).
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Further, a positive correlation was found between IL-I /3 and TNFa
release (r = 0.84, P < 0.005). These findings show that during peritonitis
peritoneal macrophages are primed (in vivo) to release more IL-l/3 and
TNFa (in vitro) following stimulation with LPS, indicating that activa-
tion of PMØ for IL-lj3 and TNFa secretion occurs in stepwise manner.
Reliability of creatinine as a marker of glomerular filtration after oral
ingestion of cimetidine. MA. Artz, L.B. Hi/brands, J.F.M. Wetzels,
R.A.P. Koene, Division of Nephrology, University Hospital N/jmegen,
The Netherlands. Creatinine does not meet all the criteria of a "true
filtration marker", mainly because of the existence of renal tubular
secretion of creatinine. Use of the creatinine clearance therefore leads
to an overestimation of the GFR. Cimetidine (C) is a competitive
antagonist of the secretion of creatinine. To investigate whether the
administration of C can improve the reliability of creatinine as a marker
of glomerular filtration, we compared the creatinine clearance with the
simultaneously determined clearance of 51Cr-EDTA, after oral inges-
tion of C. This study was performed in 10 healthy individuals and in 32
patients with various degrees of renal impairment (32 M; 10 F, median
GFR: 66.6 mI/mm, range 7.7 to 126.5). The dose of C and the duration
of ingestion were adjusted to renal function and ranged from 0.8 to 2
g/day and from 1 to 7 days, respectively. Creatinine concentrations
were measured using an enzymatic method. The renal plasma clearance
of 51Cr-EDTA was determined as described by Brochner-Mortensen.
After administration of C, the serum creatinine level rose in all
participants, with a median value of 25 smol/1iter, and a range from 6 to
173 (P  0.001). When expressed as a percentage of the baseline serum
creatinine the median rise was 23.4%, range 2.8 to 48.4% (P 0.001).
The mean ratio (±sD) of creatinine clearance to 51Cr-EDTA clearance
after ingestion of C was 1.01 0.13, which does not differ significantly
from unity. Subdivision of the study population according to renal
function revealed that the ratio did not depend on the degree of renal
impairment (GFR> 80 mI/mm: 1.04 0.08; GFR 40 to 80 mllmin: 1.00
0.07; GFR <40 mI/mm: 0.98 0.20, no significant differences). The
results suggest that, after oral ingestion of cimetidine, creatinine
becomes a more reliable marker of glomerular filtration.
Do correlations between age, renal hemodynamics and renal reserve
filtration capacity (RRFC) exist? P.M. ter Wee, R.O.B. Gans, A.M.
Tegzess, A.J.M. Donker, Free University Hospital Amsterdam and
State University Groningen, The Netherlands. In 41 control subjects
(C), 27 uninephrectomized persons (Un) and 19 patients with a renal
transplant (Tx), GFR and effective renal plasma flpw (ERPF) were
measured with '251-iothalamate and '3I-hippurate (both by constant
infusion), respectively. RRFC was tested by infusion of dopamine (D;
1.5 to 2.0 /Lg/kg/min), amino acids (A; Vamin® N 83 ml/hr) and a
combined infusion of A + D. Baseline values for GFR and ERPF were
109 (± 18) and 450 (± 104) mI/min/! .73 m2 in C, 69.5 (± 13) and 283 (±49)
in Un, and 71.5 (±22) and 294 (±85) in Tx. The percentage of A-induced
changes in GFR and ERPF were comparable between the three groups.
In Un and Tx, D as well as A + D-induced changes in GFR and ERPF
were significantly lower compared to C. In C and Tx, age was
negatively correlated to baseline GFR (r = —0.44 and r =
—0.46,
respectively) and ERPF (r = —0.3 and r =
—0.50, respectively). No
consistent correlations between D, A or A + D-induced changes in
GFR and ERPF versus age were found. Percentage-induced changes of
GFR and ERPF during D, A and A + D were negatively correlated to
baseline GFR and ERPF only in C, not in Un and Tx. From these
results we conclude that in control subjects RRFC declined with
increasing baseline values of GFR and ERPF, but not with age, despite
a negative correlation between age versus GFR and ERPF. Thus, the
clinical importance of RRFC is questionable.
Changes in urinary albumin loss are related to changes in filtration
fraction in microalbuminuric LDDM patients. H.J.G. Bib, E. van
Ballegooie, R.O.B. Gans, B.J. Potter van Loon, K. Bakker, R.P.J.
Michels, A.J.M. Donker, Nzjmegen, Amsterdam, Zwolle, Haarlem and
Leiden, The Netherlands. To investigate possible differential effects of
various antihypertensive drugs in insulin-dependent diabetes mellitus
(IDDM), we studied the acute effects of ACE inhibition (ACE, 25 mg
captopril, N = 7), calcium channel blockade (CCB, 20mg nifedipine, N
= 8) and placebo (P, N 9) in normotensive, microalbuminuric IDDM
patients. GFR (mi/mm, '251-iothalamate), ERPF (mI/mm, '311-hip-
puran), filtration fraction (FF = GFR/ERPF) and blood pressure (mm
Hg, BP) were measured at baseline (BL) and 1, 2 and 3 hours after
tablet ingestion. In the ACE group, FF fell (BL = 0.26 0.03 vs. 2 hr
= 0.24 0.02, P < 0.05), and in both the ACE and the CCB group mean
arterial pressure (MAP) fell by 6 to 8 mm Hg when comparing the BL
and 2 hr results. In a subgroup of 15 patients (5 P, 5 ACE, 5 CCB)
urinary albumin excretion rate (UAER) was measured hourly. In 6 FF
fell (1 P, 4 ACE, 1 CCB; BL = 0.28 0.04 vs. 2 hr = 0.25 0.04), in
5FF rose (2 P, 1 ACE, 2 CCB; BL = 0.23 0.02 vs. 2 hr = 0.25 0.01)
and in 4 patients FF remained unaltered (2 P. 2 CCB; 0.24 0.02).
Irrespective of the kind of active drug or placebo ingested or the
changes in MAP, a fall in FF was accoqpanied by a fall in UAER (%
UAER =
—34.4 10.9%). A rise in FF was associated with a rise in
UAER (% UAER = +38.0 3.l%; Mann-Whitney U-test between
both groups, P < 0.01). With an unaltered FF, UAER remained
unaltered (% UAER = 1.6 11.5%). In our opinion, these results
underscore the importance of intrarenal haemodynamic changes in
patients with IDDM, especially when trying to influence UAER.
Sodium depletion enhances the antiproteinuric effect of ACE inhibition
(ACE1) in established adriamycin (ADM) nephrosis in the rat. R.T.
Gansevoort, D. de Zeeuw, P.E. de Jong, P. KIok, J.J. Weening,
Department of Medicine, Division of Nephrology, and Department of
Pathology, University of Groningen, The Netherlands. Literature on
ACEi in experimental nephrosis mostly deals with preventing the
development of proteinuria and glomerulosclerosis. Only a few studies
have investigated the effect of ACEI on established proteinuria and
have shown equivocal results. In man sodium depletion is necessary to
obtain an optimal antiproteinuric effect of ACEi. We therefore studied
the effects of ACEi in 10 male Wistar rats with established ADM
induced nephrosis (3 mg/kg ADM iv.) with different sodium status. All
rats were fed a low salt diet (0.05% NaCI) during 6 weeks. Rats were
then matched for proteinuria and BP. One group continuing the low salt
diet (LS), the other receiving a "high" salt diet; 0.3% NaCI, compara-
ble to standard chow (HS). After 4 weeks of stabilization no differences
existed between the two groups in BP and proteinuria (I). Addition of
the ACEi lisinopril (L; 2.5 mg/kg) lowered proteinuria and BP signifi-
cantly in both groups, stabilizing after 4 weeks (II). The antiproteinuric
effect in the LS group was significantly greater compared to HS (P <
0.05). The BP lowering effect was also, albeit not significantly, en-
hanced. Withdrawal of the drug resulted in an increase of BP and
proteinuria to pre-L values (III).
LS
I II III
BP mm Hg 135 Il 102 14 134 8
UNa mmol/day 0.04 0.02 0.13 0.05 0.07 0.05
Up0 mg/day 595 254 105 89 552 228
C1 mI/mm 0.92 0.15 0.90 0.28 0.94 0.11
SAIb mmol/liter 20.8 5.8 29.8 2.7 23.0 4.3
HS
I II III
139 5 129 17 137 12
0.35 0.11 0.44 0.16 0.47 0.21
621 230 293 151 678 229
0.93 0.14 1.10 0.31 0.98 0.35
21.0 5.3 26.4 4.2 22.6 4.1
Conclusion: ACEi lowers proteinuria and BP in male Wistar rats with
established ADM nephrosis. Sodium depletion potentiates these ef-
fects. We hypothesize that the equivocal results of studies on antipro-
teinuric effects of ACEi in experimental established nephrosis might be
in part due to differences in sodium status.
The antigen recognized by Wegener's granulomatosis autoantibodies is
a fourth protease of azurophilic granules. KM. Dolman, R. Gold-
schmeding, M.E. van den Ende, A. Sonnenberg, A.E.G.Kr. von dem
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Borne, Central Laboratory of the Netherlands Red Cros.c Blood Trans.
fusion Service and Laboratory for Experimental and Clinical Immunol-
ogy, University of Amsterdam, Amsterdam, The Netherlands. In the
serum of patients suffering from Wegener's granulomatosis (WG)
antineutrophil cytoplasmic autoantibodies (ANCA) can be detected by
indirect immunofluorescence, producing a cytoplasmic staining pattern
(C-ANCA). These autoantibodies are directed against a serine protease
with Mr 29,000 to 32,000, located in the azurophil granules of polymor-
phonuclear leucocytes (PMN) and in the granules of monocytes. In a
previous study we have demonstrated that this serine protease is
distinct from neutrophil elastase (NE) and cathepsin 0, but its relation
to other neutrophil lysosomal serine proteases has not been firmly
established. We performed a comparative analysis of these enzymes by
the techniques that were originally used for their identification. By
immunoaffinity chromatography, FpHPLC, and N-terminal sequence
analysis, the 29-kD C-ANCA antigen appeared to be identical to
proteinase p29b/AGP7, and the C-ANCA antigen isolated by Ludemann
et al. Dye-ligand affinity chromatography indicated that the 29-kD
C-ANCA antigen is the same enzyme as the proteinase studied by Kao
et al, which was called proteinase 3 by these investigators. However,
analysis by discontinuous nondenaturing polyacrylamide gel electro-
phoresis showed that this latter enzyme is not the proteinase 3 originally
described as such. The results indicate that the antigen recognized by
WG autoantibodies is not identical to the originally described protein-
ase 3.
Quantification of adhesion of cultured glomerular epithelial cells by
using anti-DNA antibodies in ELISA. W. Coers, R.J. T. Smeenk, D.J.
Salant, J. Grond, J.J. Weening, Department of Pathology, University
of Groningen, Central Laboratory of the Blood Transfusion Service,
Amsterdam, The Netherlands, and Renal Section, Boston University,
Boston, Massachusetts, USA. Glomerular epithelial cells (GEC) con-
stitute a tight filtration barrier on the outer side of the glomerular
capillary wall. Endowed with actin and vimentin filaments, GEC
provide strength to counterbalance the transcapillary hydraulic pres-
sure. GEC are anchored to the glomerular basement membrane (GBM)
through cytoskeleton-integrin matrix interactions. Detachment from the
GBM mediated by toxins, intracapillary hypertension or immune reac-
tions is a hallmark of GEC injury associated with increased permeabil-
ity and proteinuria. To study the cellular and molecular basis of GEC
detachment, we developed a sensitive ELISA as a tool to quantify
attachment of cultured rat GEC to plastic surfaces coated with different
matrix proteins under varying conditions. GEC, derived from a cell
line, were cultured to confluency, trypsinized and plated onto 96-well
culture dishes coated with matrix molecules. GEC were allowed to
attach during different time intervals between 15 and 90 minutes at
different temperatures. At each interval, non-adhering cells were re-
moved by centrifugation. Attached cells were fixed with methanol and
incubated with a monoclonal anti-DNA antibody. Following standard
procedures, the amount of bound antibody was quantified by ELISA.
The results showed a good correlation between 0D492 and the number
of attached cells as determined by morphometric analysis using phase
contrast microscopy, within the range of 100 to 5000 cells per well
(correlation coefficient values in separate experiments were approxi-
mately r = 0.95, P < 0.001). Attachment was found to be logarithmic
with time and to be maximal within the first 90 minutes. Adhesion and
spreading of GEC was also found to be temperature dependent. GEC
primed on collagen type I showed significant adhesion differences when
plated onto respectively collagen type I, fibronectin or EHS-laminin.
Attachment to these matrixmolecules decreased in the above-men-
tioned order in a concentration-dependent manner. In conclusion, this
relatively simple immunoassay allows exact calculation of cell adhesion
under different experimental conditions.
A mathematical model of hemodiafiltration: application to drug clear-
ance. H.H. Vincent, MC. Vos, E. Akcahuseyin, W.A. van Duyl,
M.A .D.H. Schalekamp, Department of Internal Medicihe I and Bio-
medical Physics and Technology, Erasmus University Rotterdam, The
Netherlands. We recently developed a mathematical model of solute
transport by combined convection and diffusion. The model provides an
expression of the diffusive mass transfer coefficient (Kd, sm/min) as a
function of the membrane surface area and blood, filtrate and dialysate
flow rates and solutes concentrations. From a previous study in
CAVHD patients, we were able to predict Kd of creatinine for the
AN-69 0.6 m2 capillary dialyzer under various circumstances. We now
simultaneously determined Kd values of urea, creatinine, phosphate
and of a number of antibiotic drugs during CAVHD. Furthermore, we
determined Kd values of urea, creatinine and vitamin B12 from labo-
ratory clearance measurements. For solutes up to 1200 daltons, we
found an inverse linear correlation between Kd and the square root of
the solute molecular weight. This suggests that for small solutes, the
diffusion rate is determined by the random walk velocity of the
molecule rather than by its size. This relationship between Kd and
molecular weight was used, together with data on drug protein binding
and sieving, to predict Kd values and clearance rates of tobramycine,
several cephalosporines, imipenem, ciprofloxacin and vancomycin dur-
ing CAVHD. Comparison of observed and predicted values of drug
clearance yielded a coefficient of variation of 19% (N = 62). A similar
approach may be used to analyze and predict the clearance of drugs in
intermittent hemodialysis or hemodiafiltration.
Effect of a platelet activating factor (PAF) antagonist on renal metab-
olism during endotoxin shock in rats. A.A. van Lambalgen, M.F. van
der Vaart-Mulder, A.A. van Kraats, T. Teerlink, G.C. van den Bos,
L.G. Thijs, A.J.M. Donker, Laboratory for Physiology and Clinical
Chemistry and Department of Internal Medicine, Free University,
Amsterdam, The Netherlands. During endotoxin shock renal metabo-
lism is affected by hypoperfusion and nephrotoxic effects of endotoxin
which aggravates acute renal failure and may lead to irreversible
damage. Endotoxin most likely acts through mediators, such as PAF.
We therefore wanted to know whether a specific PAF-antagonist, BN
52021 (BN), prevented metabolic changes during endotoxin shock. In
17 anesthetized rats we infused E. coli 0127.B8 endotoxin (8 mg/kg)
from t = 0 to 60 mm; 7 of these rats received BN (40 mg/kg .hr, from
—30 mm to t = 0). A third group served as control (no endotoxin,N = 10). We measured cardiac output (CO. thermodilution), arterial
lactate concentration and renal metabolism (lactate, glucose, ATP, CrP
and energy charge as FATP + 0.5ADP]/[ATP + ADP + AMP]) in
biopsies taken at t 135 mm (end of experiment) and calculated
glomerular filtration rate (GFR) and renal plasma flow (RPF) from
plasma disappearance rate of 1311-hippurate and '251-thalamate, respec-
tively, from t = 90 to 135 mm. A fall in CO and rise of serum lactate,
characteristic for shock, occurred in both endotoxin-treated groups;
decrease in CO was not significantly (NS) different (by —28 vs. —40%:
BN-treated vs. untreated groups), but the increase in serum lactate
level was less in BN-treated rats (by +210 vs. +720%, P < 0.05). The
PAF-antagonist did not prevent the fall in RPF (by —54 vs. —60%, NS)
or GFR (by —52 vs. —60%, NS). Renal metabolism in BN-treated rats,
however, was comparable with that in controls except for a compara-
tively small increase in lactate concentration (by + 170%, P < 0.05),
while in rats not receiving the PAF-antagonist lactate concentration
increased by +490% (P < 0.05) and ATP, CrP and energy charge
decreased by —62, —51 and —30%, respectively (P < 0.05 compared
with controls). Our results show that although the PAF-antagonist did
not prevent acute renal failure during endotoxin shock, renal metabo-
lism was better preserved so that occurrence of irreversible damage will
most likely be delayed.
Renal effects of ibopamine in patients with severe congestive heart
failure. A.R.J. Girbes, C.J. Kalisvaart, D.J. Van Veidhuisen, A.J.
Smit, W.H. Pasteuning, Department of Medicine, University Hospital,
Groningen and Department of Cardiology, Elizabeth Hospital, Tilburg,
The Netherlands. Renal plasma flow is decreased in congestive heart
failure (CHF). Dopamine is known to increase ERPF not only as a
result of augmenting cardiac output but also by stimulation of vascular
DA1-dopamine receptors. lbopamine (Ib) is an orally active, aselective
dopamine agonist intended for use in congestive heart failure. We have
reported earlier that lb transiently increases GFR, but not ERPF in
healthy subjects. The effects of lb on renal hemodynamics, sodium
excretion, blood pressure (BP) and heart rate (HR) were investigated in
10 patients (mean age 71, range 52 to 82 years) with severe CHF, class
IV NYHA. All patients used ACE-inhibitors, digoxin and diuretics.
After determining baseline values a single oral dose of 100 mg lb was
administered. GFR and ERPF were measured simultaneously using
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radiopharmaceuticals. Results: data are expressed as medians (95%
confidence intervals).
GFR ERPF
FFmi/min/1.73 m2
Baseline 48 (42—61) 144 (111—192) 0.34 (0.30—0.41)
After lb
1 hr 55 (45_75)a 167 (128—221) 0.38 (0.32—0.42)
2hr 58(48_7l)a 146(13l—211Y' 0.37(0.32—0.40)
3 hr 57 (49—72r 153 (125_235)a 0.36 (0.31—0.41)
4 hr 57 (46—66) 155 (118—229) 0.36 (0.29—0.41)
a P < 0.05
lb induced a statistically significant, but clinically not significant, rise in
absolute sodium excretion: baseline 1.0 to a maximum 1.2 mmol/hr. No
changes in fractional sodium excretion, PRA, aldosterone, norepineph-
rine, BP and HR were observed. We conclude that lb increases ERPF
and GFR in patients with severe CHF, possibly as a consequence of
both inotropic cardiac (alpha and beta receptor stimulation) and specific
renal effects. The lack of the presumed renal vasodilation may be the
consequence of the expected DA1-induced renal vasodilation, reversed
by the alpha adrenergic properties of lb for this dose.
Different antihypertensive effect of beta-blockade in renal transplant
recipients with or without host kidneys. H. W. van Hamersvelt, J.D. van
Bergeyk, J.F.M. Smits, R.A.P. Koene, F.Th.M. Huysmans, Depart-
ment of Nephrology, University Hospital N(jmegen and Department of
Pharmacology, University of Maastricht, The Netherlands. Hyperten-
sion after renal transplantation (Tx) is frequently due to the presence of
host kidneys (HK), especially in patients with glomerulonephritis (GN).
In such patients, we retrospectively observed a large decrease of blood
pressure (BP) on beta-blockade, whereas BP did not change in Tx
patients with prior bilateral nephrectomy (BN). Therefore, we prospec-
tively studied in a double-blind way the antihypertensive effect of the
beta-blocker metoprolol (M, durette 200 mg bid, 2 wks) and placebo (P)
in Tx patients, 10 HK patients with GN and 9 BN patients (all
untreated, NaC1 intake 9 g/day). HK and BN patients were comparable
for BP (HK: 143 19/96 12 mm Hg, BN: 163 20/102 5, means
SD), age, body weight and endogenous creatinine clearance. Besides
BP (Dinamap), plasma renin activity (PRA) and plasma levels of
norepinephrine (NE) and epinephrine (E) were measured. Compared to
P, M had a larger antihypertensive effect (P = 0.056) in HK patients
(—11.6 2.4%, P = 0.002, mean saM) than in BN patients (—3.5
3.3%, P = 0.45). During P, PRA was higher and NE lower in HK than
in BN patients (PRA: 3.5 0.9 vs. 1.2 0.3 nmol/liter/hr, P = 0.008;
NE: 0.7 0.1 vs. 1.3 0.2 nmol/liter, P = 0.003). During M, PRA
decreased (P < 0.02) in HK patients by —64 4% and in BN patients
by —52 10%. NE increased in HK patients (+31 13%, P = 0.04)
and did not change in BN patients (—10 13%). No changes in E were
observed. Only in HK patients, a higher PRA during P was associated
with a larger decrease in BP on M (r = 0.64, P = 0,048). Thus, despite
the observed renin reduction, beta-blockade does not seem useful for
lowering blood pressure in BN patients, possibly due to a low baseline
PRA. The role of NE in this respect cannot be readily explained. In
contrast, in Tx patients with HK, beta-blockers are effective antihyper-
tensive drugs, and our data suggest that reduction of renin secretion in
the HK is responsible for this BP lowering effect.
Vasoactive and inflammatory mediators modulate growth of rat mesan-
gial cells (MCs) in culture. A. Wolthuis, A. Boes, J.J. Weening, J.H.M.
Berden, J. Grond, Department of Pathology, University of Groningen,
and Department of Medicine, Division of Nephrology, University of
Nijmegen, The Netherlands. Mesangial expansion due to cellular
hyperplasia and increased deposition of extracellular matrix (ECM) is
encountered in various glomerulopathies. In disease states, prolifera-
tive and biosynthetic activity of MCs may be altered by a number of
factors, such as composition of pericellular ECM and soluble vasoac-
tive and inflammatory substances penetrating the mesangium from the
circulation or secreted locally by intrinsic glomerular cells, infiltrating
macrophages, and/or sequestered platelets. The present initial study
examined growth activity of cultured rat MCs in response to a number
of such vasoactive and inflammatory mediators. Subconfluent MCs
(passage # 7 to 10) were rendered quiescent by incubation for four days
in resting medium containing 0.5% fetal calf serum (FCS). Subse-
quently, MCs were exposed in resting medium for three days to arginine
vasopressin (AVP), serotonin (5-HT), and angiotensin II (Ang II) in
concentrations varying from l0— to 10-8 M, crude macrophage-condi-
tioned medium (mØ-CM) which was prepared by culture of peritoneal
mØ of normal rats in resting medium (2 x 106/ml) for two days in
dilutions of 1:10 to 1:10,000, and recombinant interleukin 6 (rIL-6, 0.1
to 250 U/mI). Heparin (hep) and N-desulfated acetylated heparin
(DSA-hep, devoid of anticoagulant activity) were added in quantities of
0.01 to 1,000 g/ml to growth medium containing 10% FCS to assess
possible growth inhibitory effects. All experiments were conducted in
fivefold. Cellular proliferation was assayed at day 3 by measuring 32
hour DNA synthesis (ELISA assay of incorporated bromodeoxyuri-
dine, a thymidine analog) and by counting cell numbers. AVP and 5-HT
were clearly mitogenic with a maximal stimulation of 40% of the
mitogenic effect of growth medium at concentrations of lO_6 M, Ang II
was less potent (20% stimulation). Crude mØ-CM enhanced MC growth
up to 30% of the growth medium effect in dilutions of 1:100 to 1:1000.
rIL-6 was maximally stimulatory (60%) at 10 U/mI. In contrast, hep and
DSA-hep in dosages of 100 to 1,000 g/ml strongly inhibited MC growth
(maximum: 70% inhibition of the growth medium effect). These prelim-
inary results confirm data of other investigators and indicate profound
modulation of MC growth in vitro by a variety of vasoactive and
inflammatory mediators. MC biosynthetic activities in these conditions
are currently under study.
Cytomegalovirus directly induces MHC class I and ICAM-1 expression
on cultured human proximal tubular epithelial cells. W. T. van Dorp,
P.A.M. van Wieringen, C.A. Bruggeman, MR. Daha, L.A. van Es,
F.J. van der Woude, Department of Nephrology, University Hospital
Leiden and Maastricht, The Netherlands. Human proximal tubular
epithelial cells (PTEC) can be infected with cytomegalovirus (CMV) in
vivo and in vitro. Clinically, there is an association between CMV
infections and the occurrence of rejection after renal allotransplantation
in man. Adhesion molecules such as intercellular adhesion molecule
(ICAM) and MHC antigens are thought to be important in the induction
and amplification of rejection. Therefore, we studied the ICAM-1 and
MHC expression on cultured PTEC after CMV infection or stimulation
with cytokines. Class I and /32-microglobulin (/32m) antigen expression
was increased by all tested cytokines (a-interferon [a-Infl, y-interferon[y-Infl, interleukin-la [Il-la], tumor necrosis factor-a [TNFa]).
ICAM-1 expression was induced by y-Inf and TNFa, class II expres-
sion was induced only by y-Inf. Small concentrations of a-Inf inhibited
the y-Inf induced class II expression. PTEC infected with CMV
displayed increased class I, 132m and ICAM-1 expression while class II
expression was not induced. Immunoprecipitation studies revealed no
class I antigens encoded by the CMV genome. CMV infection did not
inhibit the y-Inf induced expression of class II molecules. There was no
evidence that the increased antigen expression after CMV infection was
due to soluble factors such as a-Inf or 3-Inf. Our findings suggest that
CMV infection may trigger rejection by directly increasing the cell
surface expression of adhesion molecules and MHC antigens within the
transplanted organ.
Immunohistopathology of renal biopsies in Wegener's granulomatosis
(WG): Clues to its pathogenesis? E. Brouwer, J. W. Cohen Tervaert, J.J.
Weening, C.G.M. Kallenberg, Department of Clinical immunology,
Nephrology and Pathology, State University Hospital, Groningen, The
Netherlands. WG is strongly associated with circulating antineutrophil
cytoplasmic antibodies (ANCA), in particular antibodies to proteinase 3
(PR3) and, in some cases, myeloperoxidase (MPO). The pathogenetic
significance of ANCA is not known. Since the cationic proteins PR3 and
MPO can localize in the GBM due to charge interaction, ANCA may be
involved in the pathogenesis of WG by reacting to GBM-bound PR3 and
MPO, or by directly activating neutrophils (PMNs). Otherwise, cellular
immunity to the GBM-bound enzymes may result in crescentie glomer-
ulonephritis (CGN) comparable to mechanisms described by Rennke
(Ki 37:428, 1991). To test these hypotheses we studied 20 biopsies from
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WG patients for the presence of (cell-free) PR3 and MPO (MoAbs), Ig
and C deposition, PMNs (CDI5, CD67), (activated) T-cells (CD4, CD8;
HLA-DQ, IL2R), and monocyte/macrophages (CD14, 64, 68). In addi-
tion, biopsies were studied for ICAM- 1, ELAM-1, and LFA- Ia and 13,
in order to assess the possible upregulation of adhesion molecules. PR3
and MPO were found only within cells but not at the GBM. Only one
biopsy from an early case showed granular igG along the GBM. With
respect to the cells involved in the glomerular crescent, we found that
most cells were either CDI5-(PMNs) or CD64 (macrophages)-positive
with a predominance of CD 15; these markers were mutually exclusive.
In some early biopsies T-cells were found also within the glomerulus. In
the interstitium monocytes/macrophages predominated PMNs (1.3:1);
in addition, T-cells (CD4/8 ratio 1.54) were present but did not show
marked upregulation of HLA-DQ and/or IL2R. In contrast to ELAM- 1,
ICAM-l was expressed abundantly on glomerular and tubular epithe-
hum. The results suggest that antibody mediated as well as T-cell
mediated immune damage of the glomerulus may occur in the initial
phase, but do not support a role for planted PR3 or MPO. More early
cases, however, should be studied. PMNs dominate the effector phase
in the glomerulus. Cellular immunity predominates in the interstitium.
A nephritogenic rat monoclonal antibody to mouse aminopeptidase A.
K.J.M. Assmann, R.M. Termaat, J.P.H.F. van Son, H.B.P.M. Dyk-
man, R.A.P. Koene, Departments of Pathology and Nephrology,
University of Nymegen, Njmegen, The Netherlands. The interaction of
antibodies with antigens expressed on the cell membranes of glomerular
epithelial cells (GEC) can lead to the formation of immune complexes in
the capillary wall, as we have shown previously for antibodies to the
brush border (BB) hydrolase dipeptidyl peptidase IV. We have now
produced a IgGl monoclonal antibody (Mab) against mouse aminopep-
tidase A (APA), also known as angiotensinase A, another BB hydrolase
that is also present on GEC, The Mab (ASD-4) was prepared by fusion
of mouse myeloma cells with splenocytes of LOU rats immunized with
BB membranes from mouse kidneys. ASD-4 reacted with a 140 kD
protein as demonstrated by immunoprecipitation on radiolabeled BB
membranes. In indirect immunofluorescence (IF) and in immunoelec-
tron microscopy ASD-4 bound diffusely to the BB of the SI and S2
segments of the proximal tubules. In the glomerulus there was strong
staining of the cell membranes of GEC, juxtaglomerular cells and, to a
much lesser degree, of endothelium. By contrast, staining of endothelia
of other renal vessels was strong. In addition, cell membranes of
smooth muscle cells of arteries were also stained. Four hours after
injection of 10mg Ig of ASD-4 into normal mice, a strong homogeneous
binding along the capillary wall was seen by IF changing into a fine
granular pattern at day 1. Also, strong staining the BB of Si and S2
segments could be observed, Massive albuminuria was induced imme-
diately after injection (25.5 9.9 mg albumin/18 hr), ASD-4 is a new
rat-Mab with an immunoprecipitation and binding pattern characteristic
of an antibody against APA. It is also the first Mab that causes severe
albuminuna after in vivo administration in mouse.
Extrapulmonary angiotensin I-I! conversion in hypertensive subjects.
P.J.J. Admiraal, F.H.M. Derkx, A.H.J. Danser, M.A.D.H.
Schalekamp, Department of Internal Medicine I, University Hospital,
Erasmus University, Rotterdam, The Netherlands. To quantify angio-
tensin (Ang) I-il conversion in extrapulmonary vascular beds, ['25I]Ang
I was given via constant i.v. infusion to hypertensive subjects at the
time of diagnostic renal angiography and renal vein renin sampling.
Plasma levels of intact ['251]Ang I and II and endogenous Ang I and II
were measured in the aorta, and the forearm, femoral, renal and hepatic
veins. From these measurements Ang I-H conversion and Ang I
degradation (percent of arterial delivery) was calculated (mean SD):
-
No treatment Captopril 50 mg bid
Conversion Degradation Conversion Degradation
Forearm 24 13 41 16 5 4 38 16
Leg 35 51±11 5 51±6
Kidney < 2 83 11 < 2 80 5
Liver+gut <2 95±4 <2 96±2
Lungs + heart 60 9 17 13 10 7 33 16
Results demonstrate substantial Ang I-Il conversion in arm and leg but
little conversion in the liver and kidney. Virtually all circulating Ang II
can be accounted for by conversion of circulating Ang I. While a large
proportion of Ang I in the venous effluent of tissues, the kidney in
particular, is produced in situ in these tissues, little or no venous Ang II
seems to be derived from in situ conversion of this locally produced
Ang I. Data suggest a high degree of compartmentalization of the
different components of the renin-angiotensin system.
The ACE inhibitor lisinopril reduces proteinuria in man by restoring
glomerular permselectivity to proteins, without improving size selectivity
for dextrans. J.E. Heeg, D. de Zeeuw, P.E. de Jong, University
Hospital, Groningen, The Netherlands. ACE inhibition (ACEi) lowers
proteinuria in man. This effect may be due to restoration of the affected
glomerular perinselectivity, in association with ACEi-induced hemody-
namic effects. To test this, we studied the effects of ACEi with lisinopril
(Lisi) on fractional clearances (6) of endogenous proteins albumin (Aib,
36 A, p1 4.9), IgU (54 A, p1 5.0 to 8.5) and a2-macroglobulin (a2m, 80
A, p1 5.4), and of exogenous polydisperse neutral dextrans (20 to 65 A
radius) in 12 non-diabetic stable proteinunc patients. Clearances were
performed at the end of three 2-month study periods: (I) No medication,
(II) a-methyldopa (MD) to study the effect of blood pressure lowering,
and (III) Lisi 10 mg/day. Data are given as means (±sEM).
Control MD Lisinopril
Proteinuria g/24 hr 6.9 0.7 5.2 0.7k' 2.6
Diastolic BP mm 85 4 74 2 70 3
Hg
GFR mi/mm 86 10 82 9 80 ioa
ERPF mI/mi.., 406 47 406 40 450 45"
FF % 21.6 1.4 20.1 1.1 17.6 1,1a.b
0Alb x105 145 22 99 l4 52
0IgG x105 30 6 20 5 7 2a
Oa2m xJ05 2.6 1.3 1.6 0.5 0.6 02a,b
index t9IgG/OAlb 19.9 2.0 19.3 2.1 12.2
index 0a2m/øAlb 1.58 0.57 1.56 0.37 1.06 0,24ab
%
P < 0.05: a vs. control and b vs. MD
Blood pressure lowering with MD induced a small fall in GFR and a 24
7% fall in proteinuria without affecting protein selectivity, Dextran
sieving profiles did not change either. In contrast, associated with its
typical renal hemodynamic effects, Lisi reduced proteinuria by 63 6%
with a fall in the selectivity indices of the residual proteinuria. How-
ever, dextran sieving profiles did again not change over the whole
radius range in any patient. Assuming that dextrans are indeed valid
markers for size selectivity, we conclude that ACEi does not restore
size selectivity, but possibly reduces proteinuria by altering tubular
reabsorption or by increasing charge or configuration selectivity of the
glomerular barrier.
